BioAge Labs, Inc.
Ticker: 1709941
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 2.45-11.6% | 2.77+35.1% | 2.05-14.9% | 2.41+66.2% | 1.45 |
| Total Income | 2.45-11.6% | 2.77+35.1% | 2.05-14.9% | 2.41+66.2% | 1.45 |
| EXPENSES | |||||
| Expenditure | 31.78+12.9% | 28.15+11.8% | 25.19-7.3% | 27.18+51.8% | 17.90 |
| PROFIT | |||||
| Net Profit | -26.10-17.3% | -22.25-10.3% | -20.17+6.4% | -21.56-66.7% | -12.93 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.58-11.5% | -0.52+7.1% | -0.56+6.7% | -0.60-66.7% | -0.36 |
Corporate Events
Board MeetingBIOA
202610Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II Direct…
SEC Filing ↗